Gennova Bio gets patent to treat brain clots

The Pune-based biotech company has been granted a patent in the US for its version of drug tenecteplase, to treat brain clots (ischemic stroke), the 1st ever in the world. In India, Gennova has already started marketing Tenectase (tenecteplase) for ischemic stroke as an alternative to drug alteplase, which reduced the cost of treatment to ` 29000. The CEO of Gennova Bio is Sanjay Singh.

Leave a Reply